CVS Pharmacy, Inc. v. Doe

U.S. Supreme Court

Question(s) Presented

1. Whether section 504 of the Rehabilitation Act, and by extension the ACA, provides a disparate-impact cause of action for plaintiffs alleging disability discrimination.

2. If section 504 and the ACA create disparate-im-pact claims, whether such claims extend to the facially neutral terms and conditions of health insurance plans.

Tab Group

Merits Stage

Parties stipulate to dismissal of Rehabilitation Act disparate-impact claims challenge

November 12, 2021

U.S. Chamber files amicus brief urging Supreme Court to hold that Section 504 of the Rehabilitation Act precludes disparate-impact claims

September 10, 2021

Click here to view the amicus brief. Gregory G. Garre, Roman Martinez, and Charles S. Dameron of Latham & Watkins LLP and the U.S. Chamber’s Litigation Center served as co-counsel for the U.S. Chamber.

The U.S. Chamber previously filed an amicus brief in support of certiorari.

Petition Stage

Supreme Court grants cert to determine whether the Rehabilitation Act, and by extension the Affordable Care Act, provides a disparate-impact cause of action for plaintiffs alleging disability discrimination

July 2, 2021

U.S. Chamber files amicus brief urging Supreme Court to review and reject disparate-impact Rehabilitation Act challenges to facially neutral health-insurance plans

April 30, 2021

Click here to view the amicus brief. Gregory G. Garre of Latham & Watkins LLP and the U.S. Chamber’s Litigation Center served as co-counsel for the U.S. Chamber.

Case Documents

Appendix with Ninth Circuit Opinion -- CVS Pharmacy, Inc. v. Doe (U.S. Supreme Court).pdf

U.S. Chamber Amicus Brief -- CVS Pharmacy, Inc. v. Doe (U.S. Supreme Court).pdf

U.S. Chamber Amicus Brief (merits) -- CVS Pharmacy, Inc. v. Doe (U.S. Supreme Court).pdf